InvestorsHub Logo
Followers 13
Posts 1001
Boards Moderated 0
Alias Born 03/12/2009

Re: Jumpinjackas post# 19403

Wednesday, 01/20/2016 7:33:24 AM

Wednesday, January 20, 2016 7:33:24 AM

Post# of 20775
I have to agree and a class action suit by Darcy Paul of Paul Law Group PC could be a consequence:

“We describe [several] other suits against these defendants, either one or a group of them, in which a similar set of behaviors occurred,” Darcy Paul said. “This looks like a scheme.”

http://www.law360.com/articles/415007/biozone-founder-s-30m-suit-survives-forum-challenge


"BioZone Founder's $30M Suit Survives Forum Challenge
By Beth Winegarner

Law360, San Francisco (February 12, 2013, 7:54 PM ET) -- A California federal judge on Tuesday refused to toss a pharmaceutical company founder's $30 million lawsuit claiming BioZone Pharmaceuticals Inc.’s investors illegally stripped him of the company, saying the founder’s employment and stock-sale agreements with BioZone are too ambiguous to show the case could only be brought in New York court.
When BioZone Laboratories founder Daniel Fisher sold shares in his company to investors with Brauser Honig Frost Group, the parties entered a stock-sale agreement and an employment agreement that would provide Fisher with a job at the new BioZone Pharmaceuticals, according to court documents. Although both of those agreements contain forum-selection clauses, only one clearly requires cases against BioZone to be filed in New York, U.S. District Judge William Alsup ruled.

“These two agreements, when considered together, were ambiguous and it would be improper for this order to dismiss at this juncture,” Judge Alsup wrote. “Defendants, however, may renew their motions for … dismissal after discovery into the inclusion of the forum-selection clauses.”

BioZone intends to pursue that discovery and is confident that Judge Alsup will ultimately grant the motion, said Paul Sievers, attorney for BioZone Pharmaceuticals and for BioZone CEO Elliot Maza, investors Michael Brauser, Barry Honig and Phillip Frost, and two others named in the complaint.

However, Fisher's attorney, Darcy Paul, said he was pleased with Judge Alsup's ruling and didn't see how BioZone's next motion for dismissal on the forum-selection clause “would be different from what they propounded here.”

Fisher founded BioZone Laboratories in Pittsburg, Calif., 22 years ago; the company manufactured a variety of products, including liquid cough and cold medicines, acne medications and cosmetics, Darcy Paul said. In 2011, the investors approached Fisher about purchasing the company; after six months of negotiations, they agreed to buy all of Fisher's 6.6 million shares, 80 percent of which would be returned to him five days after the deal closed, and 20 percent of which would remain in escrow, according to his complaint.

Instead, none of Fisher's shares was returned to him, and he was never paid market value for them, the complaint said. The investors also never made good on an agreement to make Fisher an executive vice president of the company, it said.

Fisher is seeking triple damages on the more than $30 million in shares he says he lost in the deal, according to Darcy Paul. His lawsuit also accuses Brauser Honig Frost Group and its investors, many of whom became executives at BioZone Pharmaceuticals after the sale, of violating the Racketeer Influenced and Corrupt Organizations Act for engaging in a pattern of similar behavior against other companies.

“We describe [several] other suits against these defendants, either one or a group of them, in which a similar set of behaviors occurred,” Darcy Paul said. “This looks like a scheme.”

Fisher's lawsuit “looks only at one side of the story, which is not my clients' position,” Sievers said. “We have a different view of the facts.”

Daniel Fisher is represented by Darcy Paul of Paul Law Group PC.

BioZone Pharmaceuticals is represented by Paul Johnson Sievers of Manly & Stewart.

The case is Fisher v. BioZone Pharmaceuticals Inc. et al., case number 3:12-cv-03716, in the U.S. District Court for the Northern District of California.

--Editing by Jeremy Barker. "



" A Biozone founder sued Brauser, Honig, and Frost after they became involved with the predecessor company of Cocrystal. The suit was settled, but the founder is fighting on in a California state court."

http://www.barrons.com/articles/why-etfs-beat-money-managers-1417235993




"Fisher v. Biozone Pharmaceuticals, Inc. et al

Defendant: The Frost Group LLC, Elliot Maza, Brauser Honig Frost Group, Michael Brauser, Barry Honig and Biozone Pharmaceuticals, Inc.
Plaintiff: Daniel Fisher
Case Number: 3:2012cv03716
Filed: July 16, 2012
Court: California Northern District Court
Office: San Francisco Office
County: Contra Costa
Presiding Judge: Elizabeth D. Laporte
Nature of Suit: Stockholders Suits
Cause of Action: 15:78
Jury Demanded By: Plaintiff"

https://dockets.justia.com/docket/california/candce/3:2012cv03716/257225

Things that are equal to the same thing are also equal to one another (Transitive property of equality). If equals are added to equals, then the wholes are equal. If equals are subtracted from equals, then the remainders are equal. Things that coincide wi

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.